-
Je něco špatně v tomto záznamu ?
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel
N. Gökbuget, N. Boissel, S. Chiaretti, H. Dombret, M. Doubek, A. Fielding, R. Foà, S. Giebel, D. Hoelzer, M. Hunault, DI. Marks, G. Martinelli, O. Ottmann, A. Rijneveld, P. Rousselot, J. Ribera, R. Bassan
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy, směrnice pro lékařskou praxi
NLK
Free Medical Journals
od 1946 do Před 1 rokem
Freely Accessible Science Journals
od 1946 do Před 1 rokem
Open Access Digital Library
od 1946-01-01
Open Access Digital Library
od 1946-01-01
ROAD: Directory of Open Access Scholarly Resources
PubMed
38295337
DOI
10.1182/blood.2023020794
Knihovny.cz E-zdroje
- MeSH
- akutní lymfatická leukemie * diagnóza terapie MeSH
- dospělí MeSH
- lidé MeSH
- prognóza MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- směrnice pro lékařskou praxi MeSH
- Geografické názvy
- Evropa MeSH
Working groups of the European LeukemiaNet have published several important consensus guidelines. Acute lymphoblastic leukemia (ALL) has many different clinical and biological subgroups and the knowledge on disease biology and therapeutic options is increasing exponentially. The European Working Group for Adult ALL has therefore summarized the current state of the art and provided comprehensive consensus recommendations for diagnostic approaches, biologic and clinical characterization, prognostic factors, and risk stratification as well as definitions of endpoints and outcomes. Aspects of treatment, management of subgroups and specific situations, aftercare, and supportive care are covered in a separate publication. The present recommendation intends to provide guidance for the initial management of adult patients with ALL and to define principles as a basis for future collaborative research.
Department of Internal Medicine Hematology and Oncology University Hospital Brno Brno Czech Republic
Department of Medicine 2 Hematology Oncology Goethe University University Hospital Frankfurt Germany
Division of Cancer and Genetics Cardiff University School of Medicine Cardiff United Kingdom
Division of Hematology Ospedale dell'Angelo Mestre Venice Italy
Erasmus MC Cancer Institute Rotterdam The Netherlands
Hematology Department of Translational and Precision Medicine Sapienza University Rome Italy
Hospital Saint Louis Assistance Publique Hôpitaux de Paris Paris France
IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori Meldola Italy
UCL Cancer Institute London United Kingdom
University Hospitals Bristol NHS Foundation Trust Bristol United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013971
- 003
- CZ-PrNML
- 005
- 20240905133323.0
- 007
- ta
- 008
- 240725s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1182/blood.2023020794 $2 doi
- 035 __
- $a (PubMed)38295337
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Gökbuget, Nicola $u Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany $1 https://orcid.org/0000000322918245
- 245 10
- $a Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel / $c N. Gökbuget, N. Boissel, S. Chiaretti, H. Dombret, M. Doubek, A. Fielding, R. Foà, S. Giebel, D. Hoelzer, M. Hunault, DI. Marks, G. Martinelli, O. Ottmann, A. Rijneveld, P. Rousselot, J. Ribera, R. Bassan
- 520 9_
- $a Working groups of the European LeukemiaNet have published several important consensus guidelines. Acute lymphoblastic leukemia (ALL) has many different clinical and biological subgroups and the knowledge on disease biology and therapeutic options is increasing exponentially. The European Working Group for Adult ALL has therefore summarized the current state of the art and provided comprehensive consensus recommendations for diagnostic approaches, biologic and clinical characterization, prognostic factors, and risk stratification as well as definitions of endpoints and outcomes. Aspects of treatment, management of subgroups and specific situations, aftercare, and supportive care are covered in a separate publication. The present recommendation intends to provide guidance for the initial management of adult patients with ALL and to define principles as a basis for future collaborative research.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a akutní lymfatická leukemie $x diagnóza $x terapie $7 D054198
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 700 1_
- $a Boissel, Nicolas $u Hospital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France $1 https://orcid.org/0000000320917927
- 700 1_
- $a Chiaretti, Sabina $u Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
- 700 1_
- $a Dombret, Hervé $u Leukemia Department, University Hospital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Saint-Louis Research Institute, Université Paris Cité, Paris, France
- 700 1_
- $a Doubek, Michael $u Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic $1 https://orcid.org/0000000212696282
- 700 1_
- $a Fielding, Adele $u UCL Cancer Institute, London, United Kingdom $1 https://orcid.org/0000000247467789 $7 xx0316854
- 700 1_
- $a Foà, Robin $u Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
- 700 1_
- $a Giebel, Sebastian $u Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland $1 https://orcid.org/0000000248274401
- 700 1_
- $a Hoelzer, Dieter $u Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany
- 700 1_
- $a Hunault, Mathilde $u Maladies du Sang University Hospital of Angers, FHU Goal, INSERM, National Centre for Scientific Research, Angers, France $1 https://orcid.org/0000000177775216
- 700 1_
- $a Marks, David I $u University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
- 700 1_
- $a Martinelli, Giovanni $u IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy
- 700 1_
- $a Ottmann, Oliver $u Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, United Kingdom $1 https://orcid.org/0000000195591330
- 700 1_
- $a Rijneveld, Anita $u Erasmus MC Cancer Institute, Rotterdam, The Netherlands
- 700 1_
- $a Rousselot, Philippe $u Clinical Hematology Department, Centre Hospitalier de Versailles, Université Paris-Saclay, Versailles, France $1 https://orcid.org/0000000332384494
- 700 1_
- $a Ribera, Josep $u Clinical Hematology Department, Institut Catala d'Oncologia-Hospital Germans Trias I Pujol, Josep Carreras Research Institute, Badalona, Spain $1 https://orcid.org/0000000310426024
- 700 1_
- $a Bassan, Renato $u Division of Hematology, Ospedale dell'Angelo, Mestre-Venice, Italy $1 https://orcid.org/0000000182142894 $7 xx0317382
- 773 0_
- $w MED00000807 $t Blood $x 1528-0020 $g Roč. 143, č. 19 (2024), s. 1891-1902
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38295337 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133317 $b ABA008
- 999 __
- $a ok $b bmc $g 2143648 $s 1225837
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 143 $c 19 $d 1891-1902 $e 20240509 $i 1528-0020 $m Blood $n Blood $x MED00000807
- LZP __
- $a Pubmed-20240725